FDA Proposes Removing Phenylephrine from Decongestants

FDA Proposes Removing Phenylephrine from Decongestants

independent.co.uk

FDA Proposes Removing Phenylephrine from Decongestants

The FDA proposes removing oral phenylephrine from over-the-counter nasal decongestants due to ineffectiveness, sparking debate among healthcare organizations.

English
United Kingdom
Us PoliticsHealthLifestyleHealthcareRegulationFdaMedicineDrug
Food And Drug Administration (Fda)Consumer Healthcare Products Association (Chpa)Proctor & GambleKenvue
Patrizia CavazzoniScott Melville
Is the FDA's proposal based on safety concerns?
The FDA's proposal is not based on safety concerns; oral phenylephrine's presence doesn't affect how other active ingredients work. The proposed removal only applies to orally administered phenylephrine, not nasal sprays.
What is the current status of products containing oral phenylephrine?
While the FDA's proposal is not yet a final order, companies can still market products containing oral phenylephrine as a nasal decongestant for now. A final order will determine which products can be marketed.
Why is the FDA proposing to remove oral phenylephrine from nasal decongestants?
The FDA proposes removing oral phenylephrine from over-the-counter nasal decongestants because data shows it's ineffective as a nasal decongestant. This action is based on a review of available data and an advisory committee's advice, and it doesn't affect the nasal spray form of phenylephrine.
What led to phenylephrine becoming the main ingredient in over-the-counter decongestants?
Phenylephrine replaced pseudoephedrine as the main ingredient in over-the-counter decongestants after pseudoephedrine-containing medicines were moved behind pharmacy counters due to potential misuse. This shift happened years ago.
How has the Consumer Healthcare Products Association (CHPA) responded to the FDA's proposal?
The Consumer Healthcare Products Association (CHPA) opposes the FDA's proposal, arguing that oral phenylephrine is the only readily available oral decongestant without restrictions. They believe consumers should have access to a wider choice of over-the-counter medications.